The 2025 UK HealthTech M&A Landscape: A Cautious but Resilient Rebound

The first half of 2025 has established a clear trajectory for the UK and broader European HealthTech M&A markets. The European digital health funding landscape, in particular, saw an impressive 52% year-on-year increase in the first half of the year, reaching $3.4 Billion across 182 deals.

This performance is particularly noteworthy because it runs contrary to the global digital health funding trend, which experienced a 13% year-on-year decline over the same period. The UK's HealthTech sector has been a key contributor to this regional strength, with the UK MedTech market alone projected to reach £15.7 Billion in 2025, and a steady growth forecast to £20.5 Billion by 2030.
  
Overall, deal volume for HealthTech M&A is on pace to exceed 2024's total. In the first half of 2025, there were 277 deals in HealthTech, which projects a full-year total well above the 467 deals recorded in 2024.Similarly, disclosed deal value is on a growth path, reaching $10.3 Billion in H1 2025, on pace to surpass the 2024 total of $19.2 Billion. However, it is important to note that only a small fraction (11%) of transactions disclose deal values, suggesting the actual value is significantly higher.
  
The resilience of this market is largely attributed to a concentration of capital in fewer but larger transactions. The first half of the year saw four mega deals of over $1 Billion globally. In Europe, a handful of large "mega-deals" valued at $100 Million or more drove a significant portion of the total venture capital investment, with seven such deals accounting for 56% of the region's total investment. This trend signifies a shift away from a "spray and pray" approach towards a more selective and strategic model of "high-conviction investment".
  
The divergence between the European market's performance and the global trend is a key indicator of the UK's unique value proposition. The UK's strong innovation capacity, supported by a clear governmental commitment to digital transformation, provides a more stable and predictable environment for scaling HealthTech solutions compared to other regions. 
  
The NHS's long-term strategic plans and substantial investment create a powerful market signal and a ready customer base, which reduces regulatory uncertainty and makes the region a highly attractive destination for capital. This institutional demand and strategic clarity serve as a significant tailwind that helps to insulate the UK HealthTech sector from broader global macroeconomic pressures.

Full report availabe at https://www.healthcare.digital/single-post/uk-healthtech-m-a-market-what-s-hot-and-what-s-not-in-2025-and-looking-ahead-into-2026

To discuss how Nelson Advisors can help your HealthTech, MedTech, Health AI or Digital Health company, please email [email protected]